Revisiting predictors of virologic response to PEGIFN + RBV therapy in HIV-/HCV-coinfected patients: the role of metabolic factors and elevated GGT levels.

Mandorfer, M

Revisiting predictors of virologic response to PEGIFN + RBV therapy in HIV-/HCV-coinfected patients: the role of metabolic factors and elevated GGT levels. [electronic resource] - Journal of viral hepatitis Jan 2014 - 33-41 p. digital

Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

1365-2893

10.1111/jvh.12118 doi


Adult
Drug Therapy, Combination--methods
Female
HIV Infections--complications
Hepatitis C, Chronic--diagnosis
Humans
Interferon-alpha--therapeutic use
Male
Middle Aged
Polyethylene Glycols--therapeutic use
Prognosis
Prospective Studies
Recombinant Proteins--therapeutic use
Ribavirin--therapeutic use
Treatment Failure
gamma-Glutamyltransferase--blood